Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00726_DB00908_nanopub.RAzobBxo2Kj4-ZlaO4SR8F1VnADmoAMeIx0bK8kBkWZnw#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00726_DB00908 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00726_DB00908 label "DDI between Trimipramine and Quinidine - Additive QTc-prolonging effects may occur, increasing the risk of serious cardiac arrhythmias. Quinidine, a CYP2D6/CYP3A4 inhibitor, may also inhibit the metabolism of Trimipramine, a CYP2D6/CYP3A4 substrate. Monitor for signs of cardiac arrhythmias and for changes in Trimipramine efficacy and toxicity if Quinidine is initiated, discontinued or dose changed. [drugbank_resource:DB00726_DB00908]" assertion.
- drugbank_resource:DB00726_DB00908 identifier "drugbank_resource:DB00726_DB00908" assertion.
- drugbank_resource:DB00726_DB00908 title "DDI between Trimipramine and Quinidine - Additive QTc-prolonging effects may occur, increasing the risk of serious cardiac arrhythmias. Quinidine, a CYP2D6/CYP3A4 inhibitor, may also inhibit the metabolism of Trimipramine, a CYP2D6/CYP3A4 substrate. Monitor for signs of cardiac arrhythmias and for changes in Trimipramine efficacy and toxicity if Quinidine is initiated, discontinued or dose changed." assertion.
- drugbank:DB00726 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00726_DB00908 assertion.
- drugbank:DB00908 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00726_DB00908 assertion.